Biocept Expands Blood-Based Test Menu to Identify Key Biomarker for Breast Cancer and Non-Small Cell and Small Cell Lung Cancers
Studies have demonstrated FGFR1 amplification as a driver for uncontrolled cell growth. Hence treatments targeting this pathway are being evaluated in a number of clinical trials currently underway.
"FGFR1 alterations have been identified in a number of cancers," said
Small cell lung cancer accounts for 10 to 15 percent of all lung cancers and has a five-year survival rate, which is less than half that of non-small cell lung cancer. Because small cell lung cancer shows symptoms much later than non-small cell lung cancer, it is typically diagnosed much later in the course of the disease after it has metastasized to other parts of the body.
"The launch of FGFR1 testing is part of our strategy to use liquid
biopsy to transform the field of personalized medicine," said
About
Forward-Looking Statements Disclaimer Statement
This release contains forward-looking statements that are based upon
current expectations or beliefs, as well as a number of assumptions
about future events. Although we believe that the expectations reflected
in the forward-looking statements and the assumptions upon which they
are based are reasonable, we can give no assurance that such
expectations and assumptions will prove to have been correct.
Forward-looking statements are generally identifiable by the use of
words like "may," "will," "should," "could," "expect," "anticipate,"
"estimate," "believe," "intend," or "project" or the negative of these
words or other variations on these words or comparable terminology. To
the extent that statements in this release are not strictly historical,
including without limitation statements as to the potential of our
diagnostic assays to improve outcomes, our impact on the field of
personalized medicine and diagnostic strategies, and planned future
offerings, such statements are forward-looking, and are made pursuant to
the safe harbor provisions of the Private Securities Litigation Reform
Act of 1995. The reader is cautioned not to put undue reliance on these
forward-looking statements, as these statements are subject to numerous
risk factors as set forth in our
View source version on businesswire.com: http://www.businesswire.com/news/home/20150701005408/en/
Investors:
LHA
jcain@lhai.com
Source:
News Provided by Acquire Media